I fail to understand how these three shares score relatively poorly to other stock. AZN in particular has moved from £70 to £88 in a month.  I accept it looks pretty overbought probably for defensive reasons, but they have had a couple of very successful drug launches this year. I was thinking it was a better place to put money than a bank account, but may have got passed that point now. OCDO looks like it really will make £42 within the next 2 years. All I hear is how expensive and overpriced it is. That was at£10! Anyone know how these scores are arrived at. Is it some clever computer software calculations or some other method?

Unlock the rest of this article with a 14 day trial

or Unlock with your email

Already have an account?
Login here